AlbR Capital

AlbR Capital is a London-based investment bank and corporate brokerage firm formed in October 2025 through the merger of Peterhouse Capital and Novum Securities. The firm provides a comprehensive suite of financial services, including corporate finance, advisory, and brokerage, primarily to companies listed on the London Stock Exchange's Main Market and AIM, as well as the Aquis Stock Exchange. AlbR Capital maintains a significant focus on the life sciences, healthcare, and technology sectors, acting as a corporate adviser and broker for numerous publicly traded entities such as Shortwave Life Sciences and ProBiotix Health. The company specializes in capital raising, IPO management, and secondary fundraisings for small and mid-cap enterprises. With a leadership team drawn from established UK financial institutions, AlbR Capital is a prominent player in the UK's capital markets for growth-stage companies.